Qun-ying C. Yang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Ependymoma: Advances in Systems Treatment Strategies.
Journal: Current neurology and neuroscience reports
Published: February 05, 2025
Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese Patients.
Journal: Chemotherapy
Published: July 31, 2024
Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option.
Journal: Frontiers in pharmacology
Published: June 15, 2022
Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.
Journal: Cancer cell international
Published: April 20, 2022
Pathological diagnosis of lung cancer based on deep transfer learning
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: November 05, 2020
Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Journal: Pathology, research and practice
Published: July 14, 2017
Postoperative functional status in patients with supratentorial superficial low-grade glioma.
Journal: World journal of surgical oncology
Published: April 07, 2017
β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
Journal: Stem cells translational medicine
Published: January 07, 2016
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.
Journal: Chinese medical journal
Published: October 21, 2015
Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Journal: Oncology reports
Published: June 16, 2015
Last Updated: 09/26/2026